Product Details
Synonyms
CTSL1, MEP, CATL, CTSL
Source
Human Cathepsin L Protein, His Tag (CAL-H52H3) is expressed from human 293 cells (HEK293). It contains AA Thr 18 - Val 333 (Accession # P07711-1).
Predicted N-terminus: Thr 18
Request for sequenceMolecular Characterization

Other Tags and Version Biotin & Other Labeled Version
This protein carries a polyhistidine tag at the C-terminus.
The protein has a calculated MW of 37.8 kDa. The protein migrates as 31-33 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE).
Endotoxin
Less than 1.0 EU per μg by the LAL method / rFC method.
Purity
>95% as determined by SDS-PAGE.
Formulation
Supplied as 0.2 μm filtered solution in 50 mM NaAc, 0.5 M NaCl, pH4.5 with glycerol as protectant.
Contact us for customized product form or formulation.
Shipping and Storage
This product is supplied and shipped on dry ice.
Please avoid repeated freeze-thaw cycles.
This product is stable after storage at:
- The product MUST be stored at -70°C or lower upon receipt;
- -70°C for 3 months under sterile conditions.
ACRO Quality Management System
Customers Also Viewed
Performance Data
SDS-PAGE

Human Cathepsin L Protein, His Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 95% (With Star Ribbon Pre-stained Protein Marker).
Bioactivity-ELISA

Immobilized Human Cathepsin L Protein, His Tag (Cat. No. CAL-H52H3) at 5 μg/mL (100 μL/well) can bind Human CD74, Fc Tag (Cat. No. CD4-H5256) with a linear range of 0.005-1.25 μg/mL (Routinely tested).
Protocol
Bioactivity
Measured by its ability to cleave the fluorogenic peptide substrate Z-LR-AMC, The specific activity is >35,000 pmol/ min/μg (QC tested).
Protocol
Customer Reviews Writing Reviews

Background
Recent Advances
- English Name:
Cathepsin L
- Category:
- Approved Drugs:
1 Details
- Drugs in Clinical Trials:
0 Details
- Highest Development Stage:
Approved
[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521



















